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Summary 
Chronic granulomatous disease (CGD) is caused by a congenital defect in phagocyte reduced 
nicotinamide dinucleotide phosphate (NADPH) oxidase production of superoxide and related 
species. It is characterized by recurrent life-threatening bacterial and fungal infections and tissue 
granuloma formation. We have created a mouse model of CGD by targeted disruption of p47p  h~ 
one of the genes in which mutations cause human CGD. Identical to the case in human CGD, 
leukocytes from p47p  h~  mice produced no superoxide and killed staphylococci ineffectively. 
p47p  h~  mice developed lethal infections and granulomatous inflammation similar to those 
encountered in human CGD patients. This model mirrors human CGD and confirms a critical 
role for the phagocyte NADPH oxidase in mammalian host defense. 
p ~hagocytes play a primary and essential role in host de- 
fense against microbes, in large part through the produc- 
tion of superoxide by the activation of a latent multicompo- 
nent phagocyte reduced nicotinamide dinucleotide phosphate 
(NADPH) 1 oxidase.  The critical  role of NADPH oxidase 
and its products of oxidative metabolism such as hydroxyl 
radical, superoxide, hydrogen peroxide, and hypochlorous acid 
(bleach) in host defense is demonstrated in humans by chronic 
granulomatous disease (CGD). CGD is a rare genetic child- 
hood disease in which phagocytes do not produce these prod- 
ucts, leading to severe infections with bacteria and fungi and 
early death (1-4).  In addition to infections, CGD patients 
display aberrant inflammatory responses and tissue granuloma 
formation, the mechanism of which is not known (5-7). Be- 
yond its role in host defense, a role for products of the NADPH 
oxidase in the generation of cataracts, malignant transforma- 
tion, adult respiratory distress syndrome, and atherogenesis 
has been hypothesized (8, 9). Recently, IFN-% a proinflamma- 
tory cytokine, has been shown to be effective prophylaxis for 
the infectious complications of CGD (10). 
Activation of the phagocyte NADPH oxidase requires the 
coordinated assembly of four structural proteins: the mem- 
brane-bound flavocytochromebss8,  composed of a heavy chain 
(gp91p  h~  11) and a light chain (p22y  h~  12), and three cyto- 
solic proteins, p47p  h~  (13, 14), p67p  h~  (15), and the GTP- 
binding regulatory protein rac (16, 17). The X-linked form 
of CGD is caused by mutations in gp91p  h~  (60% of cases), 
while the autosomal recessive forms are caused by mutations 
1 Abbreviations used in this paler: CGD, chronic granulomatous disease; ES, 
embryonic stem (cells); NADPH,  reduced nicotinamide dinucleotide 
phosphate; NBT, nitroblue tetrazolium. 
in p47P  h~  (30% of cases), p67p  h~  (5% of cases), and p22y  h~ 
(5% of cases) (18-21). The discovery of nitric oxide and the 
mouse macrophage nitric oxide synthase have disclosed novel 
mechanisms of intracdlular killing (22, 23).  The necessity 
of superoxide and related species for host defense in mammals 
that possess a phagocyte nitric oxide synthase is unknown. 
Having previously shown that mouse p47p  h~  could func- 
tionally replace human p47p  h~  in a cell-flee assay of super- 
oxide production (24), we disrupted the mouse p47~  h~ gene 
to create  a  mouse model of CGD  (25).  p47p  h~  mice 
showed a condition identical to human CGD. Their phago- 
cytes showed no respiratory burst activity and killed staphy- 
lococci poorly. At sites of infection, they developed granulo- 
mata. By 14 wk of age, 50% of animals developed spontaneous 
infections. 
Materials and Methods 
Generation of the Polyadenylated Neomycin Resistance Cassette.  The 
neomycin  resistance  cassette  was prepared  by PCR as follows:  EcoRV 
and Sinai recognition sites were generated flanking the 5' SV40s/ 
TK promoter site and the 3' PstI site of the polyadenylated  neo- 
mycin resistance  gene (pMClneo poly A; Stratagene,  La JoUa, CA). 
5'  primer  5'-ACGATATCCCCGGGCAGTGTGGTTTTGCAA- 
GAG; Y primer 5'-GAGATATCCCCGGGCTGCAGGTCGACG- 
GATCC. The fragment was cloned into pBluescript (Stratagene) 
and transfected into NIH 3T3 cells, where it conveyed  resistance 
to Geneticin  (G418; GIBCO BILL,  Gaithersburg,  MD) at 500/zg/ml 
Generation of the Homologous Recombination Construct.  A 6-8 wk 
female B6/CBA mouse genomic DNA library in lambda FIX II 
(Stratagene) was screened  with a 1.05-kb  fragment, spanning  nucleo- 
tides 18-1067 of the open reading frame, of mouse p47p  h~ cDNA 
as a probe (24). A 4.5-kb XbaI fragment containing exons 3-7 of 
p47p  h~  was  subcloned into  the  pBluescript II(+/-)  plasmid 
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nation  targeting construct was prepared by subcloning a 3.2-kb 
XbaI-Pstl fragment from the 4.5-kb XbaI fragment into a BamHI- 
deleted pBluescript II(+/-) plasmid. The cloned XbaI-PstI frag- 
ment was cleaved at the contiguous BamHI sites in the 3' terminus 
of exon 7.  The sticky ends were blunted using Klenow, and the 
1.15-kb  neomycin resistance cassette was ligated into this site in 
the forward orientation. The elimination of  both wild-type BamHI 
sites  was confirmed by sequencing. 
Generation of  Homologous Recombinant  Cell  Lines.  The embryonic 
stem cell line D3 (26) was kindly provided by Dr. Tak Mak (The 
Ontario  Cancer  Center,  Princess  Margaret  Hospital;  Toronto, 
Canada). Embryonic stem (ES) cells were cultured on mitomycin-C 
(10  #g/ml;  Boehringer  Mannheim  Biochemicals,  Indianapolis, 
IN)-treated primary embryonic fibroblasts derived from 15-d-old 
C57BL/6 embryos. Aliquots of 5  ￿  106 ES cells were electropo- 
rated with 20 #g of the linearized targeting construct. After dec- 
troporation, cells were immediately cultured with 103 U/m1 mu- 
rine leukemia inhibitory factor (ESGRO; Gibco BILL). 300 #g/ml 
geneticin was added 48 h after electroporation.  Individual G418- 
resistant colonies were transferred to 96-well plates at ,,o14 d for 
screening. G418-resistant colonies were screened by sib analysis PCR 
(27).  PCR was performed in a 50-#1 reaction containing 200 #M 
dNTP, 10 mM Tris-HCl, pH 8.3, 1.5 mM MgC12, 0.5 #M of each 
primer and 2 U  ~q polymerase (Boehringer Mannheim). Cycling 
parameters were 96~  for 30 s,  60~  for 30  s,  72~  for 2 min 
for 35  cycles. The upstream primer 5'-ACGAGTTCTTCTGAG- 
GGGATCC,  C,  CAAT-Y was located 63 bp internal to the 3' terminus 
of the polyadenylated  neomycin resistance cassette. The downstream 
primer 5'-CGTACGCCTTGATGGTTACATACG-Y  was located in 
the 5' end of exon 8. Amplification of the 1.9-kb target band was 
confirmed by Southern analysis using a 1.8-kb internal probe. PCR- 
positive clones were further  screened by Southern  analysis  with 
full-length  mouse p47v*ox  cDNA and neo  '  probes. 
Generation of  Homologous Recombinant Mice.  Microinjection of 
two  homologous  recombinant  ES  cell  clones,  implantation  of 
blastocysts into pseudopregnant females, and initial breeding of  chi- 
meric males were performed in the Transgenic Services Laborato- 
ries at The Rockefeller University (New York) according to stan- 
dard techniques  (28). Two fertile chimeric males were obtained from 
one homologous recombinant ES cell clone, IC5. Chimeric males 
were bred to C57BL/6J  females.  Agouti offspring heterozygous 
for the targeted disruption were identified by Southern analysis of 
XbaI-  and  BamHI-digested  tail  biopsy DNA  probed  with  the 
p47v~o~ cDNA and neo  r fragments, p47p  h~  +/-  animals were bred 
to each other to obtain homozygous homologous recombinants. 
The genotypes  +/+, +/-,  and  -/-  were determined  by Southern 
analysis of Barn HI-digested tail biopsy DNA probed with the mouse 
p47p  *~  cDNA and neo  r fragments. Before entry into our animal 
facility,  all animals tested negative for specific murine pathogens 
and  were  maintained  in  a  specific  pathogen-free  environment. 
Animals were maintained in sterilized microisolator cages on au- 
toclaved food, water,  and bedding,  and they were transferred to 
fresh cages weekly. Animal handling was performed by gloved han- 
dlers in an HEPA-filtered laminar flow hood. Gloves and hood sur- 
faces were cleaned with the sterilant chlorine dioxide before an- 
imal  handling.  All  necropsies  were  examined  for  sites  of 
inflammation or infection, and all suspicious  sites were cultured. 
Determination of  Biochemical  Phenotype.  For performance of the 
nitroblue  tetrazolium test  (NBT) (29-32),  murine leukocytes in 
whole blood were adhered to a glass slide and then stimulated for 
30 rain at 37~  with 100 #1 of equal parts 0.5 #g/ml PMA (Sigma 
Immunochemicals,  St.  Louis,  MO)  and  0.2%  NBT  (Sigma). 
Erythrocytes were washed off and leukocytes were counterstained 
with safranin. Flow cytometric analysis for respiratory burst activity 
was performed on PMA-stimulated whole blood as described (33). 
In  Vitro Staphylococcal Killing.  500 #1 of blood was collected 
by tail  venisection  into  microcentrifuge  tubes  containing  10  U 
Figure  1.  Targeted  disruption 
of the p47phox  gene locus. (/1) De- 
sign of the  mouse  p47p*0x tar- 
geting construct. A 3.5-kb XbaI- 
Pstl  fragment  of  the  mouse 
p47p  ho~  gene  containing  exons 
3-7 was subcloned  and the 1.15-kb 
neomycin resistance (neo  r)  cas- 
sette was cloned in the sense  direc- 
tion into the blunted BamHI sites 
in the 3' terminus ofexon 7. The 
positions of the primers used for 
PCK detection of  recombinant  ES 
cell clones are designated with 
arrows. The confirmatory probe 
for the PCR was a 1.8-kb frag- 
ment internal to the primers. The probe composed of exons 1 and 2 is 
indicated.  Numbered  solid outlined  boxes represent mapped exons of 
p47p~. Exons 1 and 2 (hatched line and boxes) have been mapped within 
the BamHI fragment but their e~act location has not been determined. 
A, Asp718; B, BamHI; E, EcoRI; P, PstI; N, Ncol; S, Smal; X, XbaI. 
(13) Southern analysis of BamHI-digested tail DNA from products of het- 
erozygous matings using mouse p47p  ho~ cDNA. The hybridizing BamHI 
fragment was augmented by 1.15 kb in the targeted allele. Filters were 
hybridized with a fragment of mouse p47p  h~  cDNA (bp 18-1067) (24). 
Hybridization with exons I and 2 alone showed the same shift of the tar- 
geted band. Similar results were obtained with XbaI digested DNA. The 
neo~ probe hybridized only in the mutated allele. The upper band present 
in all lanes was a result of hybridization to exons 8 and distal. Wild type 
(+/+),  heterozygote (+/-),  and homozygote (-/-). 
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mice. PMA-stimulated NBT reduction was detected by 
blue-black granules in p47p  ~§  (A) and p47r  h~  (B) 
phagocytes, whereas  p47r~-/-  (C) phagocytes  did not re- 
duce NBT. Two to six representative  neutrophils are shown 
in each panel (x630).  PMA-stimulated oxidation of di- 
hydrorhodamine  123 to rhodamine 123 by whole blood was 
detected as fluorescent cells in the granulocyte gate. The 
y axis records side scatter and the x axis fluorescence  inten- 
sity. p47p  ~'~247 (D) and p471,~+/-  (E) blood have similar 
populations of dihydrorhodamine-oxidizing neutrophils, 
whereas no p47p  t'~  (F)  phagocytes oxidize dihydro- 
rhodamine. 25,000  live  cell  events  were collected  per sample 
and are represented as dots. Data are representative  of six 
animals in each group. 
heparin, and 25 #1 was removed for total leukocyte and differential 
counts.  HBSS  and 2.5  x  10  ~ log phase  S. aureus were added to 
a final volume of I ml. The blood-bacteria suspension  was rotated 
gently at 37~  for 20 min to allow phagocytosis of  bacteria. Lysosta- 
phin (Sigma)  was  added to a final concentration of 2.5 U/ml to 
eliminate extracellular bacteria, and the tubes were returned to 37~ 
(34).  At 30 and 60 rain after the addition of bacteria,  10-/zl ali- 
quots were lysed in distilled water and plated in soft agar. Colonies 
were enumerated at 24-48 h. 
lntraperitoneaI Thioglycollate Challenge.  Mice (6-15 wk-old lit- 
termates) were injected intraperitoneally with 2 ml sterile thioglycol- 
late (3% wt/vol) (35). Peritoneal exudates were collected after 5 h 
by peritoneal lavage with  10 ml PBS. The total leukocyte count 
and differential were determined by a hemocytometer. 
Results 
Generation  ofp47P  h~  Mice.  We targeted exon 7 (amino 
acid 221) of the mouse p47p  h~  gene, a region known to be 
necessary for human p47e  h~  function (Fig.  1 A  and reference 
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14). ES cells were transfected with the targeting vector and 
selected in the presence of G418 (28). Resistant colonies were 
screened for homologous recombination by PCR  (27), and 
positive dones were confirmed by Southern hybridization. 
Electroporation  of 3.5  x  107  total  ES cells  yielded  1,329 
G418-resistant colonies, from which four homologous recom- 
binant clones were confirmed. Blastocyst microinjection of 
two of these clones resulted in high level chimerism of three 
male offspring. Two of these males were fertile and showed 
germline transmission  of the disrupted p47p  h~  gene (Fig.  1 
B). Heterozygote matings yielded a distribution of wild-type 
(+/+)/heterozygote (+/-)/homozygote (-/-)  progeny of 
0.47:1.0:0.52, excluding embryonic lethality. Mice were geno- 
typed by tail or ear biopsy at 3-4 wk of age, and tail venisec- 
tion was performed aseptically at 4-6 wk of age without com- 
plications.  Before  the  development  af  severe  infections, 
p47p  h~  mice were fertile, of comparable weight  to their 
unaffected littermates, and had normal peripheral blood total 
and  differential leukocyte counts. 
The p47p  h~  Phenotype.  To determine that we had suc- cessfully generated the biochemical phenotype of CGD, we 
tested phorbol myristate acetate stimulated phagocytes for 
evidence of superoxide production. As is true in human CGD 
patient  phagocytes, p47p h~  phagocytes did not reduce 
NBT to blue-black formazan (29-32),  whereas p47p h~247 
and p47p h~  phagocytes reduced NBT normally (Fig.  2 
A-C). This result was confirmed by a highly sensitive whole- 
blood assay that measures the conversion of nonfluorescent 
dihydrorhodamine 123 to fluorescent rhodamine 123 (Fig. 
2 D-F and reference 33). 
Defective Staphylococcal Killing In Vitra  Despite many func- 
tional similarities between mouse and human phagocytes, im- 
portant differences have been noted, such as the absence of 
defensins from mouse phagocytes (36) and the lack of clear 
evidence of nitric oxide production by human phagocytes (37). 
Therefore, the possibility of compensatory NADPH  oxi- 
dase-independent bactericidal pathways in the mouse was ad- 
dressed by measuring the ability of whole blood to kill Staph- 
flococcus aureus in vitro (34).  Whole blood from p47p h~ 
mice  killed  10-fold  fewer  organisms  than  p47p  h~  or 
p47p  h~  mice after 30 or 60 min of incubation (P <0.001 
and P <0.04, respectively; Fig. 3). The inclusion of lysosta- 
phin, an enzyme that kills extracellular S. aureus, in this assay 
indicates that the differences in staphylococcal viability be- 
tween the groups reflected differences in intraceUular microbi- 
cidal activity. The numbers of Gram stain-identifiable or- 
ganisms  per  phagocyte at  60  min  were 0.8  _+  0.11 for 
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Figure 3.  Impaired staphylococcal killing by whole blood in p47p h~ 
mice. Log phase staphylococci  were added to whole blood at time 0. Lysosta- 
phin was added at 20 rain of incubation  and aliquots  were removed at 
30 and 60 min for enumeration of CFU of S.  aureus.  Assays were per- 
formed in duplicate on 5-11 wk-old littermates  (n  =  6 per group).  Incu- 
bation of S. aureus in plasma alone was performed without lysostaphin. 
Data from two experiments  are presented  as means with SE. At 30 and 
60 min, p47p~-/-  whole blood permitted more staphylococci to survive 
than either p47~  "~+/+ or p47~ +/- whole blood (P <0.02 and P <0.042, 
respectively). Comparisons were made by the unpaired Student's t test (Stat- 
works,  Philadelphia,  PA). 
Elimination of phagocyte NADPH  oxidase activity in the 
mouse was therefore not completely compensated by some 
other staphylococcidal pathway. 
Abnormally Exuberant Inflammation In Vivc~  Aberrant in- 
flammation in CGD may reflect infection, either cryptic or 
overt,  or  dysregulation of the inflammatory response.  In 
humans with CGD, the inflammatory response in Rebuck 
skin windows is abnormally exuberant and prolonged (5). 
To determine whether p47p  h~  mice had a similar pheno- 
type, we injected mice intraperitoneally with the sterile irri- 
tant thioglycollate (35). Peritoneal fluid total and differential 
leukocyte counts were done at 5 h  after injection (Fig.  4). 
Twice as many total leukocytes were recruited into the peri- 
toneal  cavities  of the p47P  h~  mice compared to  their 
p47p  h~  and p47p  h~  littermates (P <0.001  and P  = 
0.001, respectively). The percentage of neutrophils was com- 
parable in the three genotypes. Since this was found at an 
early time point, it likely represents a response to the stimulus 
and not a failure of cells to senesce or return to the circula- 
tion. This process may reflect a failure to degrade chemotactic 
signals,  as has been previously hypothesized (5, 38). These 
signals may now be assayed directly and will be informative 
in the understanding of the aberrant inflammatory process 
in CGD. 
Pathology  of p47p h~  Mice  Mimics  Human  CGD. 
p47p ~~  mice spontaneously developed severe infections 
with types of organisms characteristic of human CGD, whereas 
no p47p  h~  or p47p  h~  mice maintained under the same 
conditions developed infections (P <0.001,  Fig.  5).  Gross, 
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Figure 4.  Abnormally exuberant thioglycollate peritonitis in p47v  ~,-/- 
mice. Thioglycollate was injected into the peritoneal cavities of 6-15-wk- 
old littermates,  peritoneal exudates were collected 5 h later, and total peri- 
toneal leukocyte number and differential counts were determined  (n  = 
9 per group). The p47ph~-/-  mice had more peritoneal  leukocytes after 
thioglycollate  challenge  compared  to p47p  h~247  or p47P  h~  mice (P 
=  0.001 and P <0.001, respectively). Differential counts on cytospin spec- 
imens were performed on six animals per group and showed no significant 
differences between the genotypes  (78, 75, and 81% neutrophils,  respec- 
tively). Data from three experiments are presented as mean with SE. Com- 
parisons  were made by the unpaired  Student's  t test  (Statworks). 
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Figure 5.  The  KaplanlMeier 
product probability of infection- 
free survival for 60 p47v  ~,-/-, 
47 p47~ +/-, and 28 p47~ +/+ 
mice. p47p  h~  mice spontane- 
ously developed severe infections 
confirmed at necropsy, whereas 
p47#  ~  and p47~ ~'+/+  ani- 
mals did not (P <0.001). Differ- 
ences between groups were deter- 
mined  by  computation  of the 
logrank statistic (42). 
formed on six p47p  h~  mice from the initial  cohort of 
animals are presented  (Table 1).  The deep infections  were 
caused by Staphylococcus xflosus in two animals, a hyaline septate 
mold and Lactobacillus in one animal,  and the fungus Pae- 
cilomyces in one animal. These organisms are similar (S. xyiosus) 
or identical (Paecilomyces) to those that cause life-threatening 
infections  in human CGD patients  (1-4,  39).  Four of the 
p47p  h~  animals had generalized adenopathy and spleno- 
megaly. Gross and pathologic findings from one animal with 
disseminated  S.  xylosus  are  presented  (Fig.  6).  Histology 
showed granulomatous pneumonitis with neutrophils, plasma 
ceils, lymphocytes,  macrophages,  and multinudeated giant 
cells. The  initial  cohort  (eight  p47p  h~  animals)  was 
identified by sterile metal ear tags aseptically placed, which 
may have caused local ear infection in the p47~  ~'-/-  animals. 
Subsequent observations in  52 p47p h~  animals without 
ear tags, however, showed the same rates and types of infec- 
tions. Therefore, as is seen in human CGD, absence of phago- 
cyte NADPH oxidase activity in the mouse causes suscepti- 
bility  to  severe visceral infections. 
Discussion 
We have created a mouse with the same biochemical, func- 
tional, infection susceptibility, and pathological defects found 
in human CGD. The fidelity of this phenotype to human 
Table  1.  Clinical,  Microbiological,  and Histopathological  Characteristics  of Necropsied p47~ h~  Mice 
Animal  Sex/age at  necropsy  External lesions  Associated  pathology  Abscesses  Granulomas  Microbiology 
1  F/15 wk  Ear  Lymphadenopathy  Ear  -  S.  xylosus 
Feet  Splenomegaly  Feet  -  S.  xflosus 
Lung  +  S.  xflosus 
2  F/15  wk  Ear  Lymphadenopathy  Ear  -  S.  xylosus 
Splenomegaly  Lung  +  S.  xylosus 
3  M/9 wk  None  None  Lung  +  Septate  hyaline mold* 
Lactobacilhs 
4  F/11  wk  Ear  Lymphadenopathy  None  +  None 
Splenomegaly 
5  F/13  wk  Ear  Lymphadenopathy  Lung  +  Paecilomyces 
Splenomegaly 
6  F/8  wk  None  Lymphadenopathy  None  -  None 
Animals listed were from the initial ear-tagged cohort. Animals without ear tags had similar pathology. 
* Fungal elements seen on Gomori methenamine silver staining of lung tissue; fungal cultures were not performed. 
755  Jackson  et al. Figure  6.  Gross  and pathologic  anatomy  of disseminated 
S. xylosus infection in a p47P  h~  mouse. (A) An abscess 
of  the left  hindpaw (arrow)  of a 15-wk-old  female. This mouse 
also had cutaneous abscesses  of the right periauricular soft 
tissue and the right forepaw.  The lesions  were  fluctuant and 
grew 8. xylosus  in culture. (B) Necropsy  of  the mouse  shown 
in A. A 5-mm pyogranuloma  of the right caudal lobe of 
the lung is indicated (arrow). (C) Multinudeated giant cells 
were found throughout the inflammatory lung tissue  indi- 
cated in B. Characteristic granulomatous  inflammation was 
found interspersed with acute inflammation (hematoxylin 
and eosin stain, x630). 
CGD shows that there are no other biochemical systems in 
the mouse that completely compensate for the loss of prod- 
ucts of the NADPH oxidase system. The p47p  h~  mouse 
is therefore likely to be informative  for the exploration  of 
NADPH oxidase mediated functions in infectious and inflam- 
matory processes. The hypothesized roles for superoxide and 
related species in the pathogenesis of atherosclerosis, cataract 
formation, carcinogenesis, vasculitis, reperfusion injury, and 
aging  can now be defined (8,  9). 
Pollock et al. have created a homologous recombinant mouse 
model of the X-linked gp91ph~  form of CGD (40). 
Their animals showed no NBT or cytochrome C reduction, 
had abnormally exuberent thioglycollate responses, and were 
more  susceptible to infections  with  the  human  pathogens 
S, aureus and AspergiUusfumigatus.  However, these infections 
had to be induced in their animals  and,  once induced,  did 
not cause granulomatous inflammation. Abnormally abundant 
intraperitoneal  thioglycollate responses seen in the gp91V~-/- 
model were modest at 4 h after instillation but pronounced 
at later time points. The p47P  h~  animals also had abnor- 
mally abundant recruitment  of neutrophils into the perito- 
neal cavity after thioglycollate instillation,  but at an earlier 
time point.  In contrast to the X-linked gp91p  h~  model, 
the p47p  h~  animals  developed high rates of spontaneous 
infection with a common mouse bacteria, S. xylosus (41),  as 
well as the characteristic  CGD  infection Paecilomyces  (39), 
confirming the critical role of the NADPH oxidase in pro- 
tection  of  the  mouse  against  rodent  as  well  as  human 
pathogens.  Furthermore,  unlike  the  X-linked  gp91p  *~ 
model, the p47~  h~  animals developed granulomatous in- 
flammation at sites of infection. The absence ofgranulomatous 
inflammation in the model of Pollock et al. may be caused by 
the relatively short duration of infection before death. The dif- 
ferences in infection susceptibility,  histopathology, and inflam- 
matory response may reflect intrinsic  differences in our models 
of X-linked  and autosomal recessive CGD,  such as the ab- 
sence  of the  cytochrome bsss  complex  in  the  gp91p  h~ 
modal. These findings are somewhat at variance with the hu- 
man disease, in which there is little phenotypic difference be- 
tween the different genotypes of CGD. Since the p47p  h~ 
and gp91eho~-/-  animal models have been produced and bred 
into similar genetic backgrounds and maintained under similar 
756  p47ph~  Mouse Knock-Out Model of Chronic Granulomatous Disease conditions, these differences may be significant. Comparison 
of these models under identical circumstances will be required 
to sort out these differences. 
Our  animal model of p47p  h~  deficiency  mimics human 
CGD and will permit definitive studies of the possible roles 
for the NADPH oxidase. Finally, this model will be inform- 
ative for testing immune modulators and human gene ther- 
apeutics for CGD in vivo. 
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